Quarterly report · Q2
6190.TEDINET S100PLXA
Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.1bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥1.3bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥638m | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥367m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | −¥133m | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥403m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | −¥128m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥129m | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥403m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | −¥129m | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥357m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥388m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥131m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥357m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | −¥131m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥2.7bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥2.3bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥2.6bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.4bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥1.5bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.2bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥828m | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.1bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.4bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.3bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.4bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.3bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.3bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.3bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥39m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥16m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥11m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥3m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥7m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥5m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥29m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥35m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥19m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥107.65 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥76.27 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-117.5 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-39.59 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-59.08 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥71.56 | 2022-04-01 → 2022-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 45.8% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.1% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.2% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 419
| Item | Context | Value | Unit |
|---|---|---|---|
| Provision for bonuses sga | Prior1YTDDuration | － | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 4696000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 3778000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 4232000 | JPY |
| Depreciation sga | Prior1YTDDuration | 5772000 | JPY |
| Depreciation sga | CurrentYTDDuration | 4031000 | JPY |
| Research and development expenses sga | Prior1YTDDuration | 89081000 | JPY |
| Research and development expenses sga | CurrentYTDDuration | 96158000 | JPY |
| Commission fee sga | Prior1YTDDuration | 40131000 | JPY |
| Commission fee sga | CurrentYTDDuration | 49284000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)中国財務局長 | |
| Filing date cover page | FilingDateInstant | 2022-11-14 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第22期第２四半期（自 2022年７月１日 至 2022年９月30日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社フェニックスバイオ | |
| Company name in english cover page | FilingDateInstant | PhoenixBio Co.,Ltd. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役 島田 卓 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)広島県東広島市鏡山三丁目４番１号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)（082）431-0016（代表） | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)専務取締役管理部長 田村 康弘 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)広島県東広島市鏡山三丁目４番１号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)（082）431-0016（代表） | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)専務取締役管理部長 田村 康弘 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E32153 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 61900 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)株式会社フェニックスバイオ | |
| Filer name in english | FilingDateInstant | PhoenixBio Co.,Ltd. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Current fiscal year start date | FilingDateInstant | 2022-04-01 | |
| Current period end date | FilingDateInstant | 2022-09-30 | |
| Type of current period | FilingDateInstant | Q2 | |
| Current fiscal year end date | FilingDateInstant | 2023-03-31 | |
| Previous fiscal year start date | FilingDateInstant | 2021-04-01 | |
| Comparative period end date | FilingDateInstant | 2021-09-30 | |
| Previous fiscal year end date | FilingDateInstant | 2022-03-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |